-
June 6, 2013
Leukemia & Lymphoma Society honors Ohi’s research
Puck Ohi, Ph.D., assistant professor of Cell and Developmental Biology, has received the Leukemia & Lymphoma Society SCHOLAR award for his research on the role of enzymes that affect cell division, which has implications for treating cancer and blood disorders like leukemia and lymphoma. -
May 21, 2013
West Tennessee Healthcare and Vanderbilt University Medical Center announce academic affiliation agreement
-
April 4, 2013
Cancer studies reveal new genetic variants
The future of cancer is becoming clearer. And it’s not looking so good for cancer. -
April 1, 2013
Fingers and toes: joint forming factor
The gene Has2 participates in signaling that is important in developing fingers and toes, and may have relevance for cancer development. -
March 21, 2013
Patient’s cancer journey inspires fund for research
There’s a long list of Vanderbilt faculty and staff who made an impact on Terri and Steve Voland when Steve was treated at Vanderbilt-Ingram Cancer Center for a rare type of cancer in his neck and spine. -
March 20, 2013
New drugs a good BET for brain cancer
A novel class of drugs that target “BET” proteins may have broad utility for treating genetically diverse brain tumors. -
February 28, 2013
Vaccination key to preventing HPV-related cancers
Vaccinating young males and females against several types of human papillomavirus (HPV) could dramatically reduce the incidence of HPV-related cancers worldwide, according to Douglas Lowy, M.D., deputy director of the National Cancer Institute.